Assertion: relaxin | /r/HasAspect | detrimental off-target effects
Facets:
value: simultaneously
type: MANNER
Source sentences:
text: In this study, we developed a novel theranostic nanomedicine by targeting relaxin (RLX) that is known to possess potent anti-fibrotic properties but simultaneously has poor pharmacokinetics and detrimental off-target effects.